Početna › Multipla skleroza › Kalifornija
Kliničke studije za Multipla skleroza u državi Kalifornija
24 studija za Multipla skleroza traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Službeni tekst studije (engleski)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Fresno
- TG Therapeutics Investigational Trial Site, Newport Beach
- TG Therapeutics Investigational Trial Site, Orange
- i još 1
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0114, Loma Linda
- University of California Davis Health, Sacramento
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06680037A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 14. kol 2026. · NCT07304154Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 64 godina · Žene · Ažurirano 11. kol 2026. · NCT06940323A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
U tijeku regrutacijaFaza 1/2
Od 18 do 55 godina · Oba spola · Ažurirano 2. srp 2026. · NCT05359653Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
- Byers Hall, San Francisco
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 8. lip 2026. · NCT07510607ECoG BMI for Motor and Speech Control
- University of California San Francisco, San Francisco
U tijeku regrutacija
Od 21 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT03698149Care in Multiple Sclerosis (MS)
- University of California, San Francisco, San Francisco
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT07011914Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
U tijeku regrutacijaFaza 1
Od 18 do 60 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT07139743Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- University of California San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 18 do 55 godina · Oba spola · Ažurirano 11. ožu 2026. · NCT02521311A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 27. velj 2026. · NCT06138132Central Vein Sign in Multiple Sclerosis Extension Study
- Cedars-Sinai Medical Center, Los Angeles
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 20. velj 2026. · NCT07424027"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 31. lis 2025. · NCT07222618Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 80 godina · Oba spola · Ažurirano 2. svi 2025. · NCT05395624Kesimpta (Ofatumumab) Pregnancy Registry
- University of California San Diego OTIS, La Jolla
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 100 godina · Oba spola · Ažurirano 14. sij 2025. · NCT05634967Entire-body PET Scans for Multiple Sclerosis
- Brain Health Alliance, Ladera Ranch
U tijeku regrutacijaRana faza 1Zdravi dobrovoljci dobrodošli
Od 25 do 55 godina · Oba spola · Ažurirano 7. sij 2025. · NCT04390009Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- Novartis Investigative Site, La Jolla
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Žene · Ažurirano 16. svi 2024. · NCT04933552MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošliNavodi plaćanje za sudionike
Od 18 godina i više · Oba spola · Ažurirano 6. velj 2024. · NCT05204459Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.